Canfund Ventures

Canfund Ventures Corporation is a Canadian private investment firm and venture capital organization that serves as the primary operating entity for the Johnson Family Office. Established in 1982 by Douglas Johnson, the firm specializes in microcap and start-up investments with a significant focus on the life sciences, biotechnology, and technology sectors. Canfund has played a prominent role in the financing and restructuring of various healthcare companies, including the infectious disease specialist MIGENIX and the ocular-focused iCo Therapeutics. The company's investment strategy emphasizes deep research and long-term value creation, leading to its evolution into Pathfinder Asset Management Limited in 2010. Today, Canfund continues to operate as a key component of the family office's investment infrastructure, maintaining a portfolio of diverse public and private holdings.